Clinical Trials
60 trialsPhase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
University of Iowa
Natural Progesterone for the Treatment of Recurrent Glioblastoma
Emory University
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Northwestern University
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy
Thomas Jefferson University
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)
AHS Cancer Control Alberta
Single Arm Romiplostim to Prevent CIT
Children's Hospital Medical Center, Cincinnati
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
5-ALARMS
University of Colorado, Denver
Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma
OHSU Knight Cancer Institute
VARTUTRACE
Var2 Pharmaceuticals
Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma
University of California, Irvine
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Memorial Sloan Kettering Cancer Center
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
Mayo Clinic
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Jonsson Comprehensive Cancer Center
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
University of Rochester
CLIC-YYC-GPNMB
University of Calgary
GCAR1
AHS Cancer Control Alberta
ImmunoMRI for Assessment of Tumor-associated Macrophages
Medical University of Vienna
Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
Chinese PLA General Hospital
SPS-Q2
University of Calgary
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
TOASTIT
Mayo Clinic
Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
University of California, San Francisco
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
First Affiliated Hospital of Fujian Medical University
Utility of ICG in Benign Bone Tumors
Dartmouth-Hitchcock Medical Center
PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Presage Biosciences
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
University of Southern California
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Mayo Clinic
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Base Therapeutics (Shanghai) Co., Ltd.
Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
Xiangya Hospital of Central South University
MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma
HRYZ Biotech Co.
Entacapone Combination With Imatinib for Treatment of GIST
Xiangya Hospital of Central South University
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
Mayo Clinic
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
Shanghai Yunying Medical Technology
Liposomal Bupivacaine (Exparel) in Sarcomas
Wake Forest University Health Sciences
Gemcitabine With Ascorbate Including Adolescents
University of Iowa
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
Emory University
NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
Northwestern University
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
Presage Biosciences
68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor
Peking Union Medical College Hospital
Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma
OHSU Knight Cancer Institute